Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial.
D000367:Age Factors; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001831:Body Temperature; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D012409:Rubella / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control; D012411:Rubella Vaccine; D012412:Rubella virus; D013997:Time Factors; D014611:Vaccination; D014765:Viral Vaccines
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines